Myelodysplastic syndrome: classification and changing concept

• Main Author: A Ghosh (Author)
• Format: Book
• Published: Association of Clinical Pathologists of Nepal, 2011-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2091-0797; 2091-0908; 10.3126/jpn.v1i2.5410
• Keywords: Myelodysplastic syndrome; Refractory anemia; Ring sideroblasts; MDS classification; Pathology; RB1-214
• Source: Journal of Pathology of Nepal, Vol 1, Iss 2, Pp 142-150 (2011)

<p>Myelodysplastic syndrome is a group of clonal disorders having wide range of outcome. Its classification and concept have been changed over time with better understanding of its prognosis and clinical significance. The first standard classification was FAB classification which came in 1982. It was based on findings on peripheral blood and bone marrow. Later in 2001, WHO incorporated clinical data into it and proposed a modified classification. The 2001 WHO classification made several criteria and entities more precise based on inputs from several studies. New terminologies (e.g., refractory cytopenia with multilineage dysplasia) and new group (e.g., myelodysplastic / myeloproliferative disorder) have been introduced and group like &lsquo;refractory anemia with excess blasts in transformation&rsquo; was removed. Again in 2008, in collaboration with European Association for Haematopathology and the Society for Hematopathology, as well as considering several recommendations from a group of clinical experts, WHO published a revised and updated classification. In the latest MDS classification, the clinical implications of different groups have been given more importance and also the role of cytogenetics has been re-evaluated. Several groups were again redefined (e.g., myelodysplastic syndrome &ndash; unclassified, refractory anemia with excess blasts) or eliminated (e.g., refractory cytopenia with multilineage dysplasia and ringed sideroblasts) or newly introduced (e.g., refractory cytopenia with unilineage dysplasia). Childhood MDS was considered separately as demanded by several pediatric hematologists. It was also emphasized that the diagnosis and classification of MDS mainly require identification of dysplastic morphological features, routine stains and correlation with clinical data rather than cytogenetics which may be necessary only in rare cases.</p> <p><strong>Keywords: </strong>Myelodysplastic syndrome; Refractory anemia; Ring sideroblasts; MDS classification</p> <p>DOI: http://dx.doi.org/10.3126/jpn.v1i2.5410</p> <p><em>JPN </em>2011; 1(2): 142-150</p>